| Coronavirus disease 2019 (COVID-19) from the point of view of neurologists: observation of neurological findings and symptoms during the combat against a pandemic ANÖ Acarli, B Samanci, E Ekizoğlu, A Çakar, NG Şirin, T Gündüz, ... Archives of Neuropsychiatry 57 (2), 154, 2020 | 48 | 2020 |
| Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis T Gündüz, M Kürtüncü, M Eraksoy Multiple sclerosis and related disorders 11, 1-3, 2017 | 42 | 2017 |
| Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study T Gündüz, Ö Emir, M Kürtüncü, M Mutlu, A Tumaç, Ş Akca, O Çoban, ... International journal of neuroscience 122 (11), 650-656, 2012 | 41 | 2012 |
| The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals? S Sen, R Karabudak, I Schiavetti, S Demir, S Ozakbas, M Tutuncu, ... Multiple sclerosis and related disorders 52, 102968, 2021 | 26 | 2021 |
| Characteristics of isolated spinal cord involvement in neurobrucellosis with no corresponding MRI activity: A case report and review of the literature T Gündüz, PT Tektürk, Z Yapıcı, M Kürtüncü, A Somer, SH Törün, ... Journal of the Neurological Sciences 372, 305-306, 2017 | 20 | 2017 |
| Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients M Kürtüncü, V Yılmaz, Hİ Akçay, R Türkoğlu, B Altunrende, SA Çınar, ... Journal of neuroimmunology 337, 577065, 2019 | 16 | 2019 |
| Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid O Timirci-Kahraman, Z Karaaslan, E Tuzun, M Kurtuncu, AT Baykal, ... Acta Neurologica Belgica 119, 101-111, 2019 | 15 | 2019 |
| A case of leukoencephalopathy and small vessels disease caused by a novel HTRA1 homozygous mutation T Gündüz, Y Demirkol, Ö Doğan, S Demir, NH Akçakaya Journal of Stroke and Cerebrovascular Diseases 28 (11), 104354, 2019 | 12 | 2019 |
| Enhanced NLRP3 and DEFA1B expression during the active stage of parenchymal neuro-Behçet's disease E Ugurel, E Erdag, CI Kucukali, A Olcay, E Sanli, E Akbayir, M Kurtuncu, ... in vivo 33 (5), 1493-1497, 2019 | 10 | 2019 |
| Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting … C Polat Dunya, Z Tülek, M Kürtüncü, T Gündüz, JN Panicker, M Eraksoy Neurourology and Urodynamics 40 (6), 1661-1669, 2021 | 9 | 2021 |
| CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis Y Tamam, B Gunes, E Akbayir, T Kizilay, Z Karaaslan, G Koral, B Duzel, ... Multiple sclerosis and related disorders 48, 102697, 2021 | 9 | 2021 |
| Detailed evaluation of macular ganglion cell complex in patients with multiple sclerosis KT Özbilen, T Gündüz, SNÇ Kartal, NA Ceylan, M Eraksoy, M Kürtüncü Archives of Neuropsychiatry 58 (3), 176, 2021 | 8 | 2021 |
| Prognostic factors in anti-neuronal antibody positive patients Ç Aydin, ŞY Çelik, S İçöz, C Ulusoy, T Gündüz, GA Demir, M Kürtüncü, ... Archives of Neuropsychiatry 55 (2), 189, 2018 | 8 | 2018 |
| Lesion distribution pattern of parenchymal Neuro-Behçet's disease using probability mapping AS Emekli, E Ersözlü, MA Emekli, T Gündüz, M Kürtüncü Multiple Sclerosis and Related Disorders 58, 103457, 2022 | 7 | 2022 |
| The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real‐world study from Turkey C Uzunköprü, M Tütüncü, T Gündüz, H Gümüş, S Şen, S Demir, BP Çınar, ... International Journal of Clinical Practice 75 (7), e14158, 2021 | 7 | 2021 |
| Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease T Gündüz, M Kürtüncü, Z Matur, E Tüzün, U Limon, B Tanyıldız, B İzgi, ... Journal of the Neurological Sciences 414, 116831, 2020 | 7 | 2020 |
| Orolingual dyskinesia and involuntary neck movements caused by phenytoin intoxication T Gunduz, E Kocasoy-Orhan, HA Hanagasi The Journal of Neuropsychiatry and Clinical Neurosciences 25 (4), E51-E51, 2013 | 7 | 2013 |
| The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course? S Sen, A Tuncer, S Ozakbas, C Uzunkopru, C Baba, S Demir, ... Multiple Sclerosis and Related Disorders 58, 103399, 2022 | 6 | 2022 |
| Psoriasiform eruption caused by teriflunomide in a patient with multiple sclerosis S Agirgol, M Kurtuncu, M Gurbuzel, I Tasyurek, T Gunduz Clinical Toxicology 57 (11), 1125-1127, 2019 | 6 | 2019 |
| Neurobrucellosis presenting with mania Hİ Akcay, M Kurtuncu, SY Celik, T Gunduz, M Eraksoy Acta Neurologica Belgica 117, 373-375, 2017 | 6 | 2017 |
